Cellbion Co., Ltd: debt-to-equity, ROE and more
KOSDAQ, Legal name Cellbion Co., Ltd
Latest figures are the FY2025 separate summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 54.5%
- Equity ratio
- 64.7%
- ROE
- -33.2%
- Op. margin
- -423.9%
- Rev. growth
- -15.1%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 63.5% | 61.2% | -56.4% | -496.3% | n/a |
| FY2022 separate | 266.5% | 27.3% | -233.1% | -300.8% | 92.3% |
| FY2023 separate | 51.3% | 66.1% | -48.5% | -342.8% | -16.5% |
| FY2024 separate | 16.3% | 86.0% | -24.6% | -311.7% | 55.6% |
| FY2025 separate | 54.5% | 64.7% | -33.2% | -423.9% | -15.1% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩916.9M | ₩1.8B | ₩1.5B | ₩2.3B | ₩1.9B |
| Operating profit | -₩4.6B | -₩5.3B | -₩5.0B | -₩7.1B | -₩8.2B |
| Pre-tax income | -₩4.8B | -₩6.4B | -₩3.6B | -₩7.3B | -₩7.6B |
| Net income | -₩4.8B | -₩6.4B | -₩3.6B | -₩7.3B | -₩7.6B |
| Total assets | ₩13.9B | ₩10.0B | ₩11.3B | ₩34.4B | ₩35.2B |
| Total liabilities | ₩5.4B | ₩7.3B | ₩3.8B | ₩4.8B | ₩12.4B |
| Total equity | ₩8.5B | ₩2.7B | ₩7.5B | ₩29.6B | ₩22.8B |
| Paid-in capital | ₩4.9B | ₩4.9B | ₩5.4B | ₩6.4B | ₩6.4B |
| Debt/equity (source value) | 63.5% | 266.5% | 51.3% | 16.3% | 54.5% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2010-07-21
- Listed
- 24/10/16
- Employees
- 56
- Auditor
- 정동회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101114398180
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 셀비온Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.